Publicaciones en colaboración con investigadores/as de New York University Langone Medical Center (1)

2024

  1. Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040

    Annals of Oncology, Vol. 35, Núm. 4, pp. 381-391